Lv6
2200 积分 2022-10-08 加入
The changing treatment landscape of EGFR-mutant non-small-cell lung cancer
1个月前
已完结
LINC00665 sponges miR-641 to promote the progression of breast cancer by targeting the SNF2-related CREBBP activator protein (SRCAP)
3个月前
已完结
LncRNA TUSC8 inhibits the invasion and migration of cervical cancer cells via miR‐641/PTEN axis
3个月前
已完结
New Strategies in Overcoming Acquired Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Lung Cancer
3个月前
已完结
Discovery of a Novel ERK Inhibitor with Activity in Models of Acquired Resistance to BRAF and MEK Inhibitors
5个月前
已完结
MicroRNA-targeted therapeutics for lung cancer treatment
5个月前
已完结
Increased expression of miR-641 contributes to erlotinib resistance in non-small-cell lung cancer cells by targeting NF1
6个月前
已完结
Regulators at Every Step—How microRNAs Drive Tumor Cell Invasiveness and Metastasis
11个月前
已完结
Mechanisms of drug resistance in HCC
11个月前
已完结
miRNA as a Modulator of Immunotherapy and Immune Response in Melanoma
11个月前
已完结
皖公网安备34019202002308
